DLL3 targeting peptides and constructs thereof

CR20260011APending Publication Date: 2026-05-15MARIANA ONCOLOGY INC

Patent Information

Authority / Receiving Office
CR · CR
Patent Type
Applications
Current Assignee / Owner
MARIANA ONCOLOGY INC
Filing Date
2024-06-13
Publication Date
2026-05-15
Patent Text Reader

Abstract

The present disclosure relates to targeting moieties such as peptides that can bind to DLL3. The disclosure also provides targeting constructs, which may include a targeting moiety attached, via an optional linker, to a chelating agent for association of a cargo. Methods of making the constructs and formulations thereof are also provided. Methods of using the constructs and / or formulations thereof to treat subjects, for example, to treat or prevent cancer, are also described.
Need to check novelty before this filing date? Find Prior Art